pyrenedodecanoylcarnitine has been researched along with Acute Confusional Senile Dementia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, BJ; Coleman, K; Deme, P; Eren, E; Haughey, NJ; Hollinger, KR; Huang, M; Joe, TR; Kapogiannis, D; Malvankar, MM; Mustapic, M; Nogueras-Ortiz, C; Pal, A; Rais, R; Slusher, BS; Tallon, C; Thomas, AG | 1 |
1 other study(ies) available for pyrenedodecanoylcarnitine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model.
Topics: Alzheimer Disease; Animals; Ceramides; Humans; Mice; Mice, Transgenic; Neurons | 2023 |